BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34621640)

  • 1. Poor Prognosis of Contrast-Induced Nephropathy during Long Term Follow Up.
    Liu T; Lee SR
    Chonnam Med J; 2021 Sep; 57(3):197-203. PubMed ID: 34621640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
    Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
    J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
    Sato A; Aonuma K; Watanabe M; Hirayama A; Tamaki N; Tsutsui H; Toyoaki M; Ogawa H; Akasaka T; Yoshimura M; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K; Saito Y;
    Int J Cardiol; 2017 Jan; 227():424-429. PubMed ID: 27838134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention.
    Oduncu V; Erkol A; Karabay CY; Şengül C; Tanalp AC; Fotbolcu H; Özveren O; Bitigen A; Pala S; Kırma C
    Int J Cardiol; 2013 Oct; 168(4):3480-5. PubMed ID: 23688433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can sodium fluorescein cause contrast-induced nephropathy?
    Yun D; Kim DK; Lee JP; Kim YS; Oh S; Lim CS
    Nephrol Dial Transplant; 2021 Apr; 36(5):819-825. PubMed ID: 31773157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D; Celik O; Erturk M; Kalkan AK; Uzun F; Akturk IF; Akin F; Yildirim A
    Can J Cardiol; 2016 Feb; 32(2):240-6. PubMed ID: 26255218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.
    Cho JY; Jeong MH; Hwan Park S; Kim IS; Park KH; Sim DS; Yoon NS; Yoon HJ; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2010 Nov; 56(3):300-6. PubMed ID: 20708903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Injury Molecule-1 Is Associated with Contrast-Induced Nephropathy in Elderly Patients with Non-STEMI.
    Huyut MA
    Arq Bras Cardiol; 2021 Jun; 116(6):1048-1056. PubMed ID: 33787767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
    Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
    Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Cui T; Zhao J; Bei W; Li H; Tan N; Wu D; Wang K; Guo X; Liu Y; Duan C; Chen S; Lin K; Liu Y
    Cardiol J; 2017; 24(6):660-670. PubMed ID: 28394010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of contrast nephropathy to adverse events in pulmonary emboli patients diagnosed with contrast CT.
    Yazıcı S; Kırış T; Emre A; Ceylan US; Akyüz Ş; Uzun AO; Hacı R; Terzi S; Erdem A; Yeşilçimen K
    Am J Emerg Med; 2016 Jul; 34(7):1247-50. PubMed ID: 27146455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
    Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
    Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
    J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.